Rein Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Rein Therapeutics, Inc. (RNTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 59.31 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-26
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 59.31K shares, a 125.54% increase year-over-year.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 59.31K shares, a 14.12% increase from fiscal 2024.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 51.97K shares, a 9.59% decline from fiscal 2023.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 57.48K shares, a 21.95% decline from fiscal 2022.
- Rein Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 73.65K shares, a 79.46% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-26 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-26 | 59.31K shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 59.31K shares 10-Q · filed 2025-11-14 | 59.31K shares derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 59.31K shares 10-Q · filed 2025-08-14 | 59.31K shares derived: sum of 3 quarters · filed 2025-08-14 | 62.03K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 59.31K shares 10-Q · filed 2025-05-15 | 59.31K shares derived: sum of 2 quarters · filed 2025-05-15 | 62.03K shares derived: sum of 3 quarters · filed 2025-05-15 | 84.98K shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | 2.73K shares derived: sum of 2 quarters · filed 2025-04-07 | 25.67K shares derived: sum of 3 quarters · filed 2025-04-07 | 51.97K shares 10-K · filed 2025-04-07 |
| 2024-09-30 | 2.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 25.67K shares derived: sum of 2 quarters · filed 2024-11-14 | 51.97K shares 10-Q · filed 2024-11-14 | 40.96K shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 22.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 49.25K shares 10-Q · filed 2024-08-14 | 38.23K shares derived: sum of 3 quarters · filed 2024-08-14 | 55.60K shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | 26.30K shares 10-Q · filed 2024-05-15 | 15.29K shares derived: sum of 2 quarters · filed 2024-05-15 | 32.65K shares derived: sum of 3 quarters · filed 2024-05-15 | 53.65K shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | -11.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | 6.36K shares derived: sum of 2 quarters · filed 2024-04-15 | 27.36K shares derived: sum of 3 quarters · filed 2024-04-15 | 57.48K shares 10-K · filed 2024-04-15 |
| 2023-09-30 | 17.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-13 | 38.37K shares derived: sum of 2 quarters · filed 2023-10-13 | 68.50K shares 10-Q · filed 2023-10-13 | -1.60M shares derived: sum of 4 quarters · filed 2023-10-13 |
| 2023-06-30 | 21.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 51.13K shares 10-Q · filed 2023-08-11 | -1.62M shares derived: sum of 3 quarters · filed 2023-08-11 | -1.28M shares derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | 30.13K shares 10-Q · filed 2023-05-08 | -1.64M shares derived: sum of 2 quarters · filed 2023-05-08 | -1.30M shares derived: sum of 3 quarters · filed 2023-05-08 | 103.78K shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | -1.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -1.33M shares derived: sum of 2 quarters · filed 2023-03-20 | 73.65K shares derived: sum of 3 quarters · filed 2023-03-20 | 73.65K shares 10-K · filed 2023-03-20 |
| 2022-09-30 | 338.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 1.74M shares derived: sum of 2 quarters · filed 2022-11-01 | 1.74M shares 10-Q · filed 2022-11-01 | 1.56M shares derived: sum of 4 quarters · filed 2022-11-01 |
| 2022-06-30 | 1.40M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 1.40M shares 10-Q · filed 2022-08-15 | 1.22M shares derived: sum of 3 quarters · filed 2022-08-15 | 1.41M shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-05 | -177.72K shares derived: sum of 2 quarters · filed 2022-05-05 | 12.80K shares derived: sum of 3 quarters · filed 2022-05-05 | 289.74K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | -177.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 12.80K shares derived: sum of 2 quarters · filed 2022-03-28 | 289.74K shares derived: sum of 3 quarters · filed 2022-03-28 | 358.56K shares 10-K · filed 2022-03-28 |
| 2021-09-30 | 190.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 467.47K shares derived: sum of 2 quarters · filed 2021-11-12 | 536.28K shares 10-Q · filed 2021-11-12 | 536.28K shares derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | 276.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 345.76K shares 10-Q · filed 2021-08-11 | 345.76K shares derived: sum of 3 quarters · filed 2021-08-11 | |
| 2021-03-31 | 68.81K shares 10-Q · filed 2021-05-11 | 68.81K shares derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | 13.00K shares 10-K · filed 2021-03-24 | ||
| 2020-09-30 | 13.00K shares 10-Q · filed 2020-11-12 | |||
| 2019-12-31 | 47.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 311.76K shares derived: sum of 2 quarters · filed 2020-03-30 | 456.39K shares derived: sum of 3 quarters · filed 2020-03-30 | 461.64K shares 10-K · filed 2020-03-30 |
| 2019-09-30 | 264.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 409.05K shares derived: sum of 2 quarters · filed 2019-11-07 | 414.30K shares 10-Q · filed 2019-11-07 | 427.05K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 144.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 149.88K shares 10-Q · filed 2019-08-06 | 162.63K shares derived: sum of 3 quarters · filed 2019-08-06 | 302.17K shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | 5.25K shares 10-Q · filed 2019-05-08 | 18.00K shares derived: sum of 2 quarters · filed 2019-05-08 | 157.54K shares derived: sum of 3 quarters · filed 2019-05-08 | 453.42K shares derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | 12.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | 152.29K shares derived: sum of 2 quarters · filed 2019-03-29 | 448.17K shares derived: sum of 3 quarters · filed 2019-03-29 | 468.17K shares 10-K · filed 2019-03-29 |
| 2018-09-30 | 139.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 435.42K shares derived: sum of 2 quarters · filed 2018-11-07 | 455.42K shares 10-Q · filed 2018-11-07 | 455.42K shares derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | 295.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 315.89K shares 10-Q · filed 2018-08-07 | 315.89K shares derived: sum of 3 quarters · filed 2018-08-07 | 315.89K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | 20.00K shares 10-Q · filed 2018-05-09 | 20.00K shares derived: sum of 2 quarters · filed 2018-05-09 | 20.00K shares derived: sum of 3 quarters · filed 2018-05-09 | |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 1.00 shares derived: sum of 2 quarters · filed 2018-04-02 | 46.59K shares 10-K · filed 2018-04-02 | |
| 2017-09-30 | 1.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 46.59K shares 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | 46.59K shares 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |